Company / Book Value per Share
Dyne Therapeutics, Inc. Book Value per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$6.156
FY2024
5-year range
$1.485 / $23.782
FY2020-FY2024
Trend
+314.5%
vs FY2023
Sector context
#99 of 211
Health Care
What the data says
Book Value per Share changed +314% YoY in FY2024, a notable deviation from the 5-year average annual change of +91%.
Based on SEC 10-K filings.
$6.156 in FY2024 with a 5-year CAGR of +1.4%.
Improved from $4.536 to $6.156 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -5.2%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
#99 of 211 in Health CareTop 47% of 211This company $6.156 Sector average $213.854
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.4%, indicating consistent growth.
- In FY2024, book value per share increased 314.5% year-over-year.
- Ranks #99 out of 211 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.156 | +314.5% |
| FY2023 | $1.485 | -67.3% |
| FY2022 | $4.536 | -37.3% |
| FY2021 | $7.234 | -69.6% |
| FY2020 | $23.782 | +313.9% |
| FY2019 | $5.746 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026